Suchergebnisse - "Kister, Ilya"

PubPharm (166)

1

Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid

enthalten in: Annals of neurology | 2024

von Redenbaugh, V. | Fryer, J. | Cacciaguerra, L. | +24

2

Heart Rate Variability (HRV) serves as an objective correlate of distress and symptom burden in multiple sclerosis

enthalten in: International journal of clinical and health psychology : IJCHP | 2024

von Pilloni, G. | Best, P. | Kister, I. | +1

3

Longitudinal study of immunity to SARS-CoV2 in Ocrelizumab-treated multiple sclerosis patients up to 2 years after COVID-19 vaccination

enthalten in: bioRxiv.org | 2024

von Kister, I. | Curtin, R. | Piquet, A. | +17

4

Relapsing White Matter Disease and Subclinical Optic Neuropathy : From the National Multiple Sclerosis Society Case Conference Proceedings

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von O'Neill, K. | Dugue, A. | Abreu, N. | +15

5

Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders

enthalten in: Current neurology and neuroscience reports | 2023

von Aoun, R. | Gratch, D. | Kaminetzky, D. | +1

6

African American patients with Multiple Sclerosis (MS) have higher proportions of CD19+ and CD20+ B-cell lineage cells in their cerebrospinal fluid than White MS patients

enthalten in: Multiple sclerosis and related disorders | 2023

von Xue, H. | Arbini, A. | Melton, H. | +1

CommentIn: Nat Rev Neurol. 2024 Jan;20(1):5-6. - PMID 37990136

7

Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders

enthalten in: Current neurology and neuroscience reports | 2023

von Aoun, R. | Gratch, D. | Kaminetzky, D. | +1

8

No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis : Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS)

enthalten in: Neurology. Clinical practice | 2023

von Kister, I. | Oh, C. | Douglas, E. | +6

9

Pearls & Oy-sters : CSF1R-Related Leukoencephalopathy With Spinal Cord Lesions Mimicking Multiple Sclerosis

enthalten in: Neurology | 2023

von Jain, A. | Arena, V. | Steigerwald, C. | +3

10

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS) : a multicentre, randomised, single-blind, phase 4, non-inferiority trial

enthalten in: The Lancet. Neurology | 2023

von Corboy, J. | Fox, R. | Kister, I. | +25

CommentIn: Lancet Neurol. 2023 Jul;22(7):543-545. - PMID 37353269

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]